Thursday, September 15 Friday, September 16 Saturday, September 17 Sunday, September 18 Breakout Sessions
2011 Symposium Agenda Saturday, September 17
Breakfast in Exhibit Hall
Is Mastectomy the Treatment of Choice in Women Less Than 35 at Diagnosis? Monica Morrow, MD
Adjuvant Therapy in the Very Young Ann Partridge, MD, MPH
Break
Chemotherapy and the Obese Patient: An Increasing Problem Jennifer Griggs, MD
The Incidence and Biology of Metachronous Second Primary Breast Cancer Seema Khan, MD
11:00 am
Anti-HER2 Therapy in Nonexpressing HER2 Breast Cancer Norman Wolmark, MD
Is there a Role for Preoperative Targeted Therapy for DCIS? Henry Kuerer, MD, PhD
Improving the Response Rate to Endocrine Therapy V. Craig Jordan, OBE, PhD, DSc
Debate: CYP2D6 Testing Should be a Routing Part of Clinical Practice Pro: Matthew Goetz, MD Con: George Sledge Jr., MD
Questions and Answers
Multidisciplinary Tumor Board: Case Reviews and Audience Response Moderator Monica Morrow, MD
Panelists John Michael Dixon, BSc, MBChB, MD William Gradishar, MD Nora Hansen, MD George Sledge Jr., MD